4956-56-3 Usage
Uses
Used in Pharmaceutical Industry:
4-aminobenzene-1,2-diol is used as a pharmaceutical compound for its inhibitory activity against matrix metalloproteinase (MMP). MMPs are a family of enzymes involved in the breakdown of extracellular matrix in normal biological processes, as well as in disease processes such as cancer and metastasis. By inhibiting MMPs, 4-aminobenzene-1,2-diol can potentially be used in the development of therapeutic agents for various diseases, including cancer.
Used in Research Applications:
4-aminobenzene-1,2-diol is used as a research tool for studying the role of matrix metalloproteinases in various biological processes. It can be employed in in vitro and in vivo experiments to investigate the effects of MMP inhibition on cell behavior, tissue remodeling, and disease progression.
Used in Drug Development:
4-aminobenzene-1,2-diol can be used as a lead compound in the development of new drugs targeting matrix metalloproteinases. Its chemical structure can be modified to improve its potency, selectivity, and pharmacokinetic properties, leading to the development of more effective therapeutic agents for diseases associated with MMP dysregulation.
Check Digit Verification of cas no
The CAS Registry Mumber 4956-56-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,9,5 and 6 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 4956-56:
(6*4)+(5*9)+(4*5)+(3*6)+(2*5)+(1*6)=123
123 % 10 = 3
So 4956-56-3 is a valid CAS Registry Number.
4956-56-3Relevant academic research and scientific papers
Synthetic method for piceatannol derivatives and pharmaceutical compounds containing the piceatannol derivatives
-
Paragraph 0023; 0040; 0041, (2017/10/31)
The piceatannol derivatives were easily synthesized using a Wittig-Horner reaction, a Colvin rearrangement and a Sonogashira reaction. According to the result of investigating the anti-inflammatory activity of compounds synthesized in RAW264.7 macrophages induced by LPS, compounds 6 to 8 showed remarkable activity at the concentration of 10 andmu;M, and a compound 7 (90.1%), a compound 8 (60.8%) and a compound 6 (55.2%) showed no cytotoxicity. The present invention aims to provide a method for efficiently synthesizing the piceatannol derivatives and to confirm the biological activity of synthesized piceatannol derivatives.COPYRIGHT KIPO 2017
